Trial intelligence / Profile preview

Montelukast treatment for nasal polyps

2008-005644-17Phase 2Completed

Sponsor
Maija Hytönen
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of montelukast in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Maija Hytönen. Primary endpoints: Symptom diary, Nasal peak inspiratory flow and 4 more. Started Sep 2008; status: completed.

02

Drugs

montelukast
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on 2008-005644-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005644-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call